Study summary

Evaluate the efficacy, safety and tolerability of a 12-week treatment of 4 doses of ASP1941 compared to placebo in combination with metformin in adult patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin alone.

Additional Study Details

Phase
2
Product
  • ipragliflozin
  • Placebo
  • Metformin
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    343
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study to Evaluate the Effect of ASP1941 in combination with Metformin in Adult Patients With Type 2 Diabetes Mellitus? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Bucharest, Romania, 020475
      Completed
      Krakow, Poland, 30-550
      Completed
      Ancona, Italy, 60100
      Completed
      Sibiu, Romania, 550371
      Completed
      Craiova, Romania, 200642
      Completed
      Warszawa, Poland, 03-003
      Completed
      Kutno, Poland, 99-330
      Completed
      Budapest, Hungary, 1036
      Completed
      Lublin, Poland, 20-044
      Completed
      Hialeah, FL, United States, 33012
      Completed
      Sibiu, Romania, 550245
      Completed
      Katowice, Poland, 40-752
      Completed
      Brasov, Romania, 500269
      Completed
      Reading, United Kingdom, RG2 0TG
      Completed
      Birmingham, United Kingdom, B15 2SQ
      Completed
      Mako, Hungary, 6900
      Completed
      Baja, Hungary, 6500
      Completed
      Chrzanow, Poland, 32-500
      Completed
      Gyongyos, Hungary, 3200
      Completed
      Milan, Italy, 20132
      Completed
      Ploiesti, Romania, 100163
      Completed
      Bucuresti, Romania, 020275
      Completed
      Los Angeles, CA, United States, 90036
      Withdrawn
      Wroclaw, Poland, 50-556
      Completed
      Cambridgeshire, United Kingdom, CB8 9PW
      Completed
      Sienna, Italy, 53100
      Completed
      Constanta, Romania, 900675
      Completed
      Coral Gables, FL, United States, 33134
      Completed
      Lasi, Romania, 700547
      Completed
      Lodz, Poland, 90-302
      Completed
      Brasov, Romania, 500365
      Completed
      Wroclaw, Poland, 50-127
      Withdrawn
      Targu Mures, Romania, 540142
      Completed
      Las Vegas, Nevada, United States, 89106
      Completed
      Balatonfured, Hungary, 8230
      Completed
      Krakow, Poland, 30-015
      Completed
      Nyiregyhaza, Hungary, 4400
      Completed
      Manchester, United Kingdom, M15 6SX
      Completed
      Kissimmee, FL, United States, 34741
      Completed
      Zalaegerszeg, Hungary, 8900
      Completed
      Wroclaw, Poland, 50-349
      Withdrawn
      Budapest, Hungary, 1097

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?